Topical Absorbable Hemostats Market Size is valued at 529.12 Million in 2024 and is predicted to reach 1135.96 Million by the year 2034 at a 8.0% CAGR during the forecast period for 2025-2034.
Increasing number of trauma and surgical procedures where only hemostatic agents can be used to manage bleeding is expected to drive the global topical hemostats market near the future. Topical absorbable hemostats including collagen, polysaccharide, gelatin, oxidized regenerated cellulose and combination hemostats comprises of an absorbable sponge, foam, pad and other material with a topical hemostatic agent used to apply on bleeding site. These products also used in surgical specialty procedures.
The Market of Topical Absorbable Hemostats is projected to witness lucrative growth over the forecast period owing to increase in demand supported by rising surgery volumes. Additionally, increasing prevalence of chronic conditions and increasing geriatric population are driving the growth of market. For instance, according to Centers for Disease Control and Prevention (CDC) statistics, more than 45% of American population suffers from at least one chronic condition requiring critical care. Moreover, companies are investing on research and development expected to fuel the growth of market. For instance, Ethicon, LLC has ongoing clinical trial intended to study for surgical powder moderate parenchymal or soft tissue intraoperative bleeding.
The Global Topical Absorbable Hemostats market is segmented on the basis of product and region. Based on the products, the market is divided into combination hemostats – pads, oxidized regenerated cellulose-based hemostats, polysaccharide-based hemostats, gelatin-based hemostats, collagen-based hemostats and others. Based on region, the market is studied across North America, Asia-Pacific, Europe, and LAMEA. Among that Europe held the largest share of the market, followed by America and Asia Pacific. On the other hand, North America is expected to dominate the market during the analysis of forecast period.
| Report Attribute | Specifications |
| Market Size Value In 2024 | USD 529.12 Million |
| Revenue Forecast In 2034 | USD 1135.96 Million |
| Growth Rate CAGR | CAGR of 8.0% from 2025 to 2034 |
| Quantitative Units | Representation of revenue in US$ Million and CAGR from 2025 to 2034 |
| Historic Year | 2021 to 2024 |
| Forecast Year | 2025-2034 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Product |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; South Korea; South East Asia |
| Competitive Landscape | 3-D Matrix Ltd, Angiotech Pharmaceuticals Inc, Anika Therapeutics Inc, APRUS Bio-Medical Innovations Pvt Ltd, Arch Therapeutics Inc, Baxter, C.R. Bard, Cellphire Inc, Covalon Technologies Ltd, Cresilon Inc, Endomedix Incorporated, Entegrion Inc, Ethicon, ETX Pharma Inc, Gamma Therapeutics Inc, GATT Technologies BV, gel-e Inc, Gelita, Haemostatix Ltd, Hemostasis LLC, HLL Lifecare Ltd, Keratin Biosciences Inc, Leader Biomedical Europe BV, LifeBond Ltd, Mallinckrodt Pharmaceuticals, Mochida Pharmaceutical Co., Ltd., Pfizer, Protege Biomedical, Resorba GmbH, Sanara MedTech Inc, Sanofi Biosurgery Inc, Sea Run Holdings Inc, Teleflex, Therus Corporation, Thrombotargets Corp, United Health Products, Inc., Xcede Technologies Inc, Z-Medica llc and Integra LifeSciences |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing and Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Global Topical Absorbable Hemostats Market Revenue (US$ Mn) by Product
Global Topical Absorbable Hemostats Market Revenue (US$ Mn) Based on Region
Europe Topical Absorbable Hemostats Market Revenue (US$ Mn) by Country
North America Topical Absorbable Hemostats Market Revenue (US$ Mn) by Country
Asia Pacific Topical Absorbable Hemostats Market Revenue (US$ Mn) by Country
Latin America Topical Absorbable Hemostats Market Revenue (US$ Mn) by Country
Middle East & Africa Topical Absorbable Hemostats Market Revenue (US$ Mn) by Country
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Topical Absorbable Hemostats Market Snapshot
Chapter 4. Global Topical Absorbable Hemostats Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Analysis of Clinical Trial/Pipeline
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. COVID 19 Impact Analysis
4.9. Major Investment, Partnerships and Collaborations in Wound Care
Chapter 5. Market Segmentation 1: Product Estimates & Trend Analysis
5.1. Product Type & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Product:
5.2.1. Combination Hemostats – Pads
5.2.2. Oxidized Regenerated Cellulose Based Hemostats
5.2.3. Polysaccharide Based Hemostats
5.2.4. Gelatin Based Hemostats
5.2.5. Collagen Based Hemostats
Chapter 6. Topical Absorbable Hemostats Market Segmentation 3: Regional Estimates & Trend Analysis
6.1. North America
6.1.1. North America Topical Absorbable Hemostats Market revenue (US$ Million) estimates and forecasts by product, 2021-2034
6.1.1.1. Combination Hemostats – Pads
6.1.1.2. Oxidized Regenerated Cellulose Based Hemostats
6.1.1.3. Polysaccharide Based Hemostats
6.1.1.4. Gelatin Based Hemostats
6.1.1.5. Collagen Based Hemostats
6.1.2. North America Topical Absorbable Hemostats Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
6.1.2.1. U.S.
6.1.2.2. Canada
6.2. Europe
6.2.1. Europe Topical Absorbable Hemostats Market revenue (US$ Million) by product, 2021-2034
6.2.1.1. Combination Hemostats – Pads
6.2.1.2. Oxidized Regenerated Cellulose Based Hemostats
6.2.1.3. Polysaccharide Based Hemostats
6.2.1.4. Gelatin Based Hemostats
6.2.1.5. Collagen Based Hemostats
6.2.2. Europe Topical Absorbable Hemostats Market revenue (US$ Million) by country, 2021-2034
6.2.2.1. Germany
6.2.2.2. France
6.2.2.3. Italy
6.2.2.4. Spain
6.2.2.5. UK
6.2.2.6. Rest of Europe
6.3. Asia Pacific
6.3.1. Asia Pacific Topical Absorbable Hemostats Market revenue (US$ Million) by product, 2021-2034
6.3.1.1. Combination Hemostats – Pads
6.3.1.2. Oxidized Regenerated Cellulose Based Hemostats
6.3.1.3. Polysaccharide Based Hemostats
6.3.1.4. Gelatin Based Hemostats
6.3.1.5. Collagen Based Hemostats
6.3.2. Asia Pacific Topical Absorbable Hemostats Market revenue (US$ Million) by country, 2021-2034
6.3.2.1. China
6.3.2.2. India
6.3.2.3. Japan
6.3.2.4. Australia
6.3.2.5. Rest of Asia Pacific
6.4. Rest of World
6.4.1. Rest of World Topical Absorbable Hemostats Market revenue (US$ Million) by product, (US$ Million)
6.4.1.1. Combination Hemostats – Pads
6.4.1.2. Oxidized Regenerated Cellulose Based Hemostats
6.4.1.3. Polysaccharide Based Hemostats
6.4.1.4. Gelatin Based Hemostats
6.4.1.5. Collagen Based Hemostats
6.4.2. Rest of World Topical Absorbable Hemostats Market revenue (US$ Million) by country, (US$ Million) 2021-2034
6.4.2.1. Latin America
6.4.2.2. Middle East & Africa
Chapter 7. Competitive Landscape
7.1. Major Mergers and Acquisitions/Strategic Alliances
7.2. Company Profiles
7.2.1. Baxter
7.2.2. C.R. Bard
7.2.3. Ethicon
7.2.4. Gelita AG
7.2.5. Pfizer
7.2.6. B. Braun Melsungen AG
7.2.7. Teleflex Incorporated.
7.2.8. Overview/Snapshot Prominent Player
7.2.9. 3-D Matrix Ltd
7.2.10. Angiotech Pharmaceuticals Inc
7.2.11. Anika Therapeutics Inc
7.2.12. APRUS Bio-Medical Innovations Pvt Ltd
7.2.13. Arch Therapeutics Inc
7.2.14. Cellphire Inc
7.2.15. Covalon Technologies Ltd
7.2.16. Cresilon Inc
7.2.17. Endomedix Incorporated
7.2.18. Entegrion Inc
7.2.19. ETX Pharma Inc
7.2.20. Gamma Therapeutics Inc
7.2.21. GATT Technologies BV
7.2.22. gel-e Inc
7.2.23. Haemostatix Ltd
7.2.24. Hemostasis LLC
7.2.25. HLL Lifecare Ltd
7.2.26. Keratin Biosciences Inc
7.2.27. Leader Biomedical Europe BV
7.2.28. LifeBond Ltd
7.2.29. Protege Biomedical
7.2.30. Resorba GmbH
7.2.31. Sanara MedTech Inc
7.2.32. Sanofi Biosurgery Inc
7.2.33. Sea Run Holdings Inc
7.2.34. Therus Corporation
7.2.35. Thrombotargets Corp
7.2.36. United Health Products, Inc.
7.2.37. Xcede Technologies Inc